SlideShare una empresa de Scribd logo
1 de 19
GLUCOSE 6 PHOSPHATE
DEHYDROGENASE DEFICENCY
SAURABH WANI
GARWARE COLLEGE
10
G6PD DISCOVERY
• In 1931: German biochemists Warburg and Christian discovered G6PD.
• ◊ They isolated G6PD enzyme from Brewer’s yeast.
• ◊ Origin name of G6PD was Zwischenferment:
• Zwischen: between
• Ferment: fermentation
GLUCOSE 6 PHOSPHATE DEHYDROGENASE
DEFICENCY
• G6PD deficiency is the most common disease producing enzyme abnormalities
in humans, affecting more than 200 million individuals worldwide.

• The highest prevalence in the Middle East, tropical Africa & Asia.
• G6PD Deficiency is caused by 400 different mutations in gene coding for G6PD,
only few of them causes the clinical symptoms of the disease.
MODE OF INHERITENCE OF G6PD DEFICENCY
It is X- linked recessive genetic disorder (gene is carried on X-chromosome).
The gene is present on the X chromosome
The inheritance follows specific pattern:

Males have one X chromosome
So, they will be diseased if they have the affected gene (xY)
Females have 2 X chromosomes
may be homozygous or heterozygous
Homozygous: are diseased (xx)
Heterozygous: are not diseased
BUT: carriers (Xx) can transfer the disease to their sons
G6PD is an metabolic enzyme is involved in pentose phosphate
pathway, especially important in red blood cell metabolism
It also protects red blood cells from the effects of potentially harmful
molecules called REACTIVE OXYGEN SPECIES
WHAT IS FAVISM ?
• Favism is formally defined as hemolytic response to the consumption of
broad beans

• Favism is disorder characterized by hemolytic reaction to the consumption
of broad beans
• All individual with favism show G6PD deficiency
• However not all individuals with G6PD deficiency
Show favism
DECREASED AMOUNTS OF REDUCED
GLUTATHIONE
DUE TO DECREASED PRODUCTION OF NADPH
• Reduction of amounts of NADPH in RBCs in G6PD deficiency causes decrease
in reduction of oxidized glutathione to reduced glutathione.
• Role of reduced glutathione in RBCs:
•

•

1- Reduced glutathione gets rid of Reactive oxygen species including
hydrogen peroxide.

2- Reduced Glutathione helps to keep sulfhydryl groups of haemoglobin
protein in the reduced state.
Reduction of production of reduced glutathione results in:
1- A decrease in detoxication of peroxides. This causes damage to RBCs
membrane and hemolysis (ending in hemolytic anemia).
2- Hemoglobin protein is denatured forming insoluble masses (Heinz
bodies). Heinz bodies attach to red cell membranes.
Membrane proteins are also oxidized.
Accordingly, red cells become rigid and removed from the circulation
by macrophages in the spleen and liver ending in anemia
Deficiency of G6PD occurs in all cells of affected individual.
It is severe in RBCs because the only pathway to form NADPH in RBCs is
pentose phosphate pathway (using G6PD).
Individuals who have inherited one of the many G6PD mutations do not show
clinical manifestation.
Some of patients with G6PD develop hemolytic anemia if they are exposed or
ingest any of the followings oxidizing agents:

Oxidant drugs:
Antibiotics : e.g. sulfamethoxazole
Antimalarial : e.g. primaquine
Antipyretics : e.g. acetanilide
G6PD VARIANTS
• Most G6PD variants are caused by point mutations in the G6PD gene.
• Some of these point mutations do not disturb the structure of the enzyme's
active site and hence, do not affect enzyme activity.
• Other point mutations may lead to production of mutant enzymes with one or
more of the following:
•
•
•

altered catalytic activity,
decrease stability
an alteration of binding affinity for NADP+ or Glucose 6-phosphate.

• The severity of diseases usually correlates with the amount of residual enzyme
activity in the patient’s red cells.
G6PD Variants can be classified into :
Class III (G6PD Group A-) :
A moderate form of the disease
RBCs contain unstable G6PD enzyme, but normal activity in younger RBCs and
reticulocytes.
Accordingly, only older RBCs are hemolysed in a hemolytic episode.

Class II mutations (G6PD Mediterranean):
More severe
G6PD enzyme shows normal stability but, very low activity in all RBCs.
Class I mutations:
It is often associated with chronic non spherocytic anemia
(occurs even in absence of oxidative stress).
Both G6PD Mediterranean and G6PD A- represent mutant enzymes that differ
from the normal variants by a single amino acid. This change is due to DNA
changes in the form of point mutations or missense mutations.
Frame shift mutations or large deletions have not been identified indicating that
the complete absence of G6PD is lethal.
DIAGNOSIS OF G6PD DEFICIENCY
HEMOLYTIC ANEMIA
• The diagnosis of G6PD deficiency is made by a quantitative
spectrophotometric analysis
• Fluorescent spot test detecting the generation of NADPH from NADP. The
test is positive if the blood spot fails to fluoresce under ultraviolet light.

• Tests based on polymerase chain reaction detect specific mutations and
are used for population screening, family studies, or prenatal diagnosis.
• In patients with acute hemolysis, testing for G6PD deficiency may be falsely
negative because older erythrocytes with a higher enzyme deficiency have
been hemolyzed.
• Female heterozygotes may be hard to diagnose because of Xchromosome mosaicism leading to a partial deficiency that will not be
detected reliably with screening tests.
FREQUENCY OF G6PD
• Prevalence of G6PD deficiency in the Indian community was first reported from
the Parsi population of Mumbai The prevalence rate of G6PD deficiency varies
between 0-28% in different caste, tribe and ethnic groups. The highest
frequency (27.94%) has been reported from Vataliya Prajapati from Surat,
Gujarat.
• A few relatively recent studies reporting the prevalence of G6PD among the
Indians and in populations of Indian origin A great variation can be observed
among the different populations of India.
• The variation can be explained in terms of the evolutionary history of the
population and their endogamous nature. High prevalence in tribes can be
explained in terms of the geographical spread of malaria. Only few studies
report the prevalence of specific variants and fewer still have reported the
prevalence of different G6PD variants at the DNA level.
CURE FOR G6PD
• The most important measure is prevention – avoidance of the drugs and foods
that cause hemolysis. Vaccination against some common pathogens (e.g.
hepatitis A and hepatitis B) may prevent infection-induced attacks.
• In the acute phase of hemolysis, blood transfusions might be necessary, or even
dialysis in acute renal failure. Blood transfusion is an important symptomatic
measure, as the transfused red cells are generally not G6PD deficient and will
live a normal lifespan in the recipient's circulation.
• Some patients may benefit from removal of the spleen (splenectomy) as this is
an important site of red cell destruction. Folic acid should be used in any
disorder featuring a high red cell turnover. Although vitamin E and selenium
have antioxidant properties, their use does not decrease the severity of G6PD
deficiency.
THANKYOU

Más contenido relacionado

La actualidad más candente

Khan arbaz ali
Khan arbaz aliKhan arbaz ali
Khan arbaz alikhan ali
 
haemoglobinopathies
haemoglobinopathieshaemoglobinopathies
haemoglobinopathiesMogha Zius
 
Interpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin studyInterpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin studyDr. Rajesh Bendre
 
Hemoglobinopathies
HemoglobinopathiesHemoglobinopathies
HemoglobinopathiesAli Faris
 
Glucose 6 Phosphate Dehydrogenase Deficiency G6PD
Glucose 6 Phosphate Dehydrogenase Deficiency G6PDGlucose 6 Phosphate Dehydrogenase Deficiency G6PD
Glucose 6 Phosphate Dehydrogenase Deficiency G6PDUCSF
 
Hemoglobinopathies
Hemoglobinopathies Hemoglobinopathies
Hemoglobinopathies Rakesh Verma
 
Approach to hemolytic anemia
Approach to hemolytic anemiaApproach to hemolytic anemia
Approach to hemolytic anemiaSarath Menon
 
Metabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesMetabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesPradeep Singh Narwat
 
approach to the diagnosis of anemia
approach to the diagnosis of anemiaapproach to the diagnosis of anemia
approach to the diagnosis of anemiaderosaMSKCC
 
Serum Protein and Albumin-Globulin Ratio
Serum Protein and Albumin-Globulin RatioSerum Protein and Albumin-Globulin Ratio
Serum Protein and Albumin-Globulin RatioASHIKH SEETHY
 
Haemoglobinopathies
HaemoglobinopathiesHaemoglobinopathies
Haemoglobinopathiesraj kumar
 
GLYCOGEN STORAGE DISEASES
GLYCOGEN STORAGE DISEASES GLYCOGEN STORAGE DISEASES
GLYCOGEN STORAGE DISEASES YESANNA
 
Lysosomal storage diseases
Lysosomal storage diseasesLysosomal storage diseases
Lysosomal storage diseasesPradeep Mampilli
 

La actualidad más candente (20)

G6PD disease.pptx
G6PD disease.pptxG6PD disease.pptx
G6PD disease.pptx
 
G6PD deficiency.ppt
G6PD deficiency.pptG6PD deficiency.ppt
G6PD deficiency.ppt
 
Khan arbaz ali
Khan arbaz aliKhan arbaz ali
Khan arbaz ali
 
G6pd
G6pdG6pd
G6pd
 
G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
 
haemoglobinopathies
haemoglobinopathieshaemoglobinopathies
haemoglobinopathies
 
Interpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin studyInterpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin study
 
Hemoglobinopathies
HemoglobinopathiesHemoglobinopathies
Hemoglobinopathies
 
Hemolytic anemia ppt presentation
Hemolytic anemia ppt presentationHemolytic anemia ppt presentation
Hemolytic anemia ppt presentation
 
Glucose 6 Phosphate Dehydrogenase Deficiency G6PD
Glucose 6 Phosphate Dehydrogenase Deficiency G6PDGlucose 6 Phosphate Dehydrogenase Deficiency G6PD
Glucose 6 Phosphate Dehydrogenase Deficiency G6PD
 
Hemoglobinopathies
Hemoglobinopathies Hemoglobinopathies
Hemoglobinopathies
 
Approach to hemolytic anemia
Approach to hemolytic anemiaApproach to hemolytic anemia
Approach to hemolytic anemia
 
Metabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesMetabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC Enzymopathies
 
approach to the diagnosis of anemia
approach to the diagnosis of anemiaapproach to the diagnosis of anemia
approach to the diagnosis of anemia
 
Serum Protein and Albumin-Globulin Ratio
Serum Protein and Albumin-Globulin RatioSerum Protein and Albumin-Globulin Ratio
Serum Protein and Albumin-Globulin Ratio
 
Haemolytic anemia
Haemolytic anemia Haemolytic anemia
Haemolytic anemia
 
Haemoglobinopathies
HaemoglobinopathiesHaemoglobinopathies
Haemoglobinopathies
 
GLYCOGEN STORAGE DISEASES
GLYCOGEN STORAGE DISEASES GLYCOGEN STORAGE DISEASES
GLYCOGEN STORAGE DISEASES
 
Bilirubin metabolism
Bilirubin metabolismBilirubin metabolism
Bilirubin metabolism
 
Lysosomal storage diseases
Lysosomal storage diseasesLysosomal storage diseases
Lysosomal storage diseases
 

Similar a G6pd

glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptxglucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptxKalyanAcharya10
 
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptxTunTunWin34
 
glucose-6-phosphate dehydrogenase (G6PD) Deficiency.pptx
glucose-6-phosphate dehydrogenase (G6PD) Deficiency.pptxglucose-6-phosphate dehydrogenase (G6PD) Deficiency.pptx
glucose-6-phosphate dehydrogenase (G6PD) Deficiency.pptxachujesenta
 
haemolytic anaemia
haemolytic anaemiahaemolytic anaemia
haemolytic anaemiaMoses Obinna
 
Final lysosomal storage diseases2
Final lysosomal storage diseases2Final lysosomal storage diseases2
Final lysosomal storage diseases2Anupam Singh
 
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.pdf
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.pdfFavism and Glucose-6-Phosphate Dehydrogenase Deficiency.pdf
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.pdfDebjyoti Paul
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismDr. Ankit Gaur
 
Estimation of G6pd Status in the Rajbangshi Population of Sushrutanagar
Estimation of G6pd Status in the Rajbangshi Population of SushrutanagarEstimation of G6pd Status in the Rajbangshi Population of Sushrutanagar
Estimation of G6pd Status in the Rajbangshi Population of SushrutanagarIOSR Journals
 
Anemia simi joju k.
Anemia simi joju k.Anemia simi joju k.
Anemia simi joju k.simisheeja
 
inbornerrorsofcarbohydratemetabolismseminaron18-2-2011-151129054802-lva1-app6...
inbornerrorsofcarbohydratemetabolismseminaron18-2-2011-151129054802-lva1-app6...inbornerrorsofcarbohydratemetabolismseminaron18-2-2011-151129054802-lva1-app6...
inbornerrorsofcarbohydratemetabolismseminaron18-2-2011-151129054802-lva1-app6...tejasvivats
 
Inborn errors of carbohydrate metabolism
Inborn errors of carbohydrate metabolismInborn errors of carbohydrate metabolism
Inborn errors of carbohydrate metabolismTapeshwar Yadav
 
COG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
COG PENTOSE PHOSPHATE PATHWAY.p khztbhptCOG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
COG PENTOSE PHOSPHATE PATHWAY.p khztbhptmbashapatrick09
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemiaRisho1012
 

Similar a G6pd (20)

Blood 111.pptx
Blood 111.pptxBlood 111.pptx
Blood 111.pptx
 
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptxglucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
 
NEONATAL G-6PD DEFICIENCY
NEONATAL G-6PD DEFICIENCYNEONATAL G-6PD DEFICIENCY
NEONATAL G-6PD DEFICIENCY
 
Acute hemolytic anemia
Acute hemolytic anemiaAcute hemolytic anemia
Acute hemolytic anemia
 
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
 
BCP G6PD-2
BCP G6PD-2BCP G6PD-2
BCP G6PD-2
 
glucose-6-phosphate dehydrogenase (G6PD) Deficiency.pptx
glucose-6-phosphate dehydrogenase (G6PD) Deficiency.pptxglucose-6-phosphate dehydrogenase (G6PD) Deficiency.pptx
glucose-6-phosphate dehydrogenase (G6PD) Deficiency.pptx
 
Anaemia
AnaemiaAnaemia
Anaemia
 
haemolytic anaemia
haemolytic anaemiahaemolytic anaemia
haemolytic anaemia
 
Final lysosomal storage diseases2
Final lysosomal storage diseases2Final lysosomal storage diseases2
Final lysosomal storage diseases2
 
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.pdf
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.pdfFavism and Glucose-6-Phosphate Dehydrogenase Deficiency.pdf
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.pdf
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
 
Estimation of G6pd Status in the Rajbangshi Population of Sushrutanagar
Estimation of G6pd Status in the Rajbangshi Population of SushrutanagarEstimation of G6pd Status in the Rajbangshi Population of Sushrutanagar
Estimation of G6pd Status in the Rajbangshi Population of Sushrutanagar
 
Anemia simi joju k.
Anemia simi joju k.Anemia simi joju k.
Anemia simi joju k.
 
inbornerrorsofcarbohydratemetabolismseminaron18-2-2011-151129054802-lva1-app6...
inbornerrorsofcarbohydratemetabolismseminaron18-2-2011-151129054802-lva1-app6...inbornerrorsofcarbohydratemetabolismseminaron18-2-2011-151129054802-lva1-app6...
inbornerrorsofcarbohydratemetabolismseminaron18-2-2011-151129054802-lva1-app6...
 
Inborn errors of carbohydrate metabolism
Inborn errors of carbohydrate metabolismInborn errors of carbohydrate metabolism
Inborn errors of carbohydrate metabolism
 
Rbc Patho B
Rbc  Patho BRbc  Patho B
Rbc Patho B
 
Rbc Patho B
Rbc  Patho BRbc  Patho B
Rbc Patho B
 
COG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
COG PENTOSE PHOSPHATE PATHWAY.p khztbhptCOG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
COG PENTOSE PHOSPHATE PATHWAY.p khztbhpt
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 

Más de Saurabh wani

Principles of mgmt ppt
Principles of mgmt pptPrinciples of mgmt ppt
Principles of mgmt pptSaurabh wani
 
Micro and biochem ppt
Micro and biochem pptMicro and biochem ppt
Micro and biochem pptSaurabh wani
 
Medicine constipation ppt
Medicine constipation pptMedicine constipation ppt
Medicine constipation pptSaurabh wani
 
Market research questionnaire based on benadryl
Market research questionnaire based on benadrylMarket research questionnaire based on benadryl
Market research questionnaire based on benadrylSaurabh wani
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationshipSaurabh wani
 
Communication skills ppt
Communication skills pptCommunication skills ppt
Communication skills pptSaurabh wani
 

Más de Saurabh wani (12)

Rotavirus
RotavirusRotavirus
Rotavirus
 
Rohit sir ppt
Rohit sir pptRohit sir ppt
Rohit sir ppt
 
Principles of mgmt ppt
Principles of mgmt pptPrinciples of mgmt ppt
Principles of mgmt ppt
 
Novartis
NovartisNovartis
Novartis
 
Mkt research
Mkt researchMkt research
Mkt research
 
Micro and biochem ppt
Micro and biochem pptMicro and biochem ppt
Micro and biochem ppt
 
Medicine constipation ppt
Medicine constipation pptMedicine constipation ppt
Medicine constipation ppt
 
Market research questionnaire based on benadryl
Market research questionnaire based on benadrylMarket research questionnaire based on benadryl
Market research questionnaire based on benadryl
 
Genetics ppt
Genetics pptGenetics ppt
Genetics ppt
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationship
 
Communication skills ppt
Communication skills pptCommunication skills ppt
Communication skills ppt
 
Rotavirus
RotavirusRotavirus
Rotavirus
 

Último

Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesShubhangi Sonawane
 

Último (20)

Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 

G6pd

  • 1. GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICENCY SAURABH WANI GARWARE COLLEGE 10
  • 2. G6PD DISCOVERY • In 1931: German biochemists Warburg and Christian discovered G6PD. • ◊ They isolated G6PD enzyme from Brewer’s yeast. • ◊ Origin name of G6PD was Zwischenferment: • Zwischen: between • Ferment: fermentation
  • 3. GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICENCY • G6PD deficiency is the most common disease producing enzyme abnormalities in humans, affecting more than 200 million individuals worldwide. • The highest prevalence in the Middle East, tropical Africa & Asia. • G6PD Deficiency is caused by 400 different mutations in gene coding for G6PD, only few of them causes the clinical symptoms of the disease.
  • 4. MODE OF INHERITENCE OF G6PD DEFICENCY It is X- linked recessive genetic disorder (gene is carried on X-chromosome). The gene is present on the X chromosome The inheritance follows specific pattern: Males have one X chromosome So, they will be diseased if they have the affected gene (xY) Females have 2 X chromosomes may be homozygous or heterozygous
  • 5. Homozygous: are diseased (xx) Heterozygous: are not diseased BUT: carriers (Xx) can transfer the disease to their sons
  • 6.
  • 7. G6PD is an metabolic enzyme is involved in pentose phosphate pathway, especially important in red blood cell metabolism It also protects red blood cells from the effects of potentially harmful molecules called REACTIVE OXYGEN SPECIES
  • 8. WHAT IS FAVISM ? • Favism is formally defined as hemolytic response to the consumption of broad beans • Favism is disorder characterized by hemolytic reaction to the consumption of broad beans • All individual with favism show G6PD deficiency • However not all individuals with G6PD deficiency Show favism
  • 9. DECREASED AMOUNTS OF REDUCED GLUTATHIONE DUE TO DECREASED PRODUCTION OF NADPH • Reduction of amounts of NADPH in RBCs in G6PD deficiency causes decrease in reduction of oxidized glutathione to reduced glutathione. • Role of reduced glutathione in RBCs: • • 1- Reduced glutathione gets rid of Reactive oxygen species including hydrogen peroxide. 2- Reduced Glutathione helps to keep sulfhydryl groups of haemoglobin protein in the reduced state.
  • 10. Reduction of production of reduced glutathione results in: 1- A decrease in detoxication of peroxides. This causes damage to RBCs membrane and hemolysis (ending in hemolytic anemia). 2- Hemoglobin protein is denatured forming insoluble masses (Heinz bodies). Heinz bodies attach to red cell membranes. Membrane proteins are also oxidized. Accordingly, red cells become rigid and removed from the circulation by macrophages in the spleen and liver ending in anemia
  • 11.
  • 12. Deficiency of G6PD occurs in all cells of affected individual. It is severe in RBCs because the only pathway to form NADPH in RBCs is pentose phosphate pathway (using G6PD). Individuals who have inherited one of the many G6PD mutations do not show clinical manifestation. Some of patients with G6PD develop hemolytic anemia if they are exposed or ingest any of the followings oxidizing agents: Oxidant drugs: Antibiotics : e.g. sulfamethoxazole Antimalarial : e.g. primaquine Antipyretics : e.g. acetanilide
  • 13. G6PD VARIANTS • Most G6PD variants are caused by point mutations in the G6PD gene. • Some of these point mutations do not disturb the structure of the enzyme's active site and hence, do not affect enzyme activity. • Other point mutations may lead to production of mutant enzymes with one or more of the following: • • • altered catalytic activity, decrease stability an alteration of binding affinity for NADP+ or Glucose 6-phosphate. • The severity of diseases usually correlates with the amount of residual enzyme activity in the patient’s red cells.
  • 14. G6PD Variants can be classified into : Class III (G6PD Group A-) : A moderate form of the disease RBCs contain unstable G6PD enzyme, but normal activity in younger RBCs and reticulocytes. Accordingly, only older RBCs are hemolysed in a hemolytic episode. Class II mutations (G6PD Mediterranean): More severe G6PD enzyme shows normal stability but, very low activity in all RBCs. Class I mutations: It is often associated with chronic non spherocytic anemia (occurs even in absence of oxidative stress).
  • 15. Both G6PD Mediterranean and G6PD A- represent mutant enzymes that differ from the normal variants by a single amino acid. This change is due to DNA changes in the form of point mutations or missense mutations. Frame shift mutations or large deletions have not been identified indicating that the complete absence of G6PD is lethal.
  • 16. DIAGNOSIS OF G6PD DEFICIENCY HEMOLYTIC ANEMIA • The diagnosis of G6PD deficiency is made by a quantitative spectrophotometric analysis • Fluorescent spot test detecting the generation of NADPH from NADP. The test is positive if the blood spot fails to fluoresce under ultraviolet light. • Tests based on polymerase chain reaction detect specific mutations and are used for population screening, family studies, or prenatal diagnosis. • In patients with acute hemolysis, testing for G6PD deficiency may be falsely negative because older erythrocytes with a higher enzyme deficiency have been hemolyzed. • Female heterozygotes may be hard to diagnose because of Xchromosome mosaicism leading to a partial deficiency that will not be detected reliably with screening tests.
  • 17. FREQUENCY OF G6PD • Prevalence of G6PD deficiency in the Indian community was first reported from the Parsi population of Mumbai The prevalence rate of G6PD deficiency varies between 0-28% in different caste, tribe and ethnic groups. The highest frequency (27.94%) has been reported from Vataliya Prajapati from Surat, Gujarat. • A few relatively recent studies reporting the prevalence of G6PD among the Indians and in populations of Indian origin A great variation can be observed among the different populations of India. • The variation can be explained in terms of the evolutionary history of the population and their endogamous nature. High prevalence in tribes can be explained in terms of the geographical spread of malaria. Only few studies report the prevalence of specific variants and fewer still have reported the prevalence of different G6PD variants at the DNA level.
  • 18. CURE FOR G6PD • The most important measure is prevention – avoidance of the drugs and foods that cause hemolysis. Vaccination against some common pathogens (e.g. hepatitis A and hepatitis B) may prevent infection-induced attacks. • In the acute phase of hemolysis, blood transfusions might be necessary, or even dialysis in acute renal failure. Blood transfusion is an important symptomatic measure, as the transfused red cells are generally not G6PD deficient and will live a normal lifespan in the recipient's circulation. • Some patients may benefit from removal of the spleen (splenectomy) as this is an important site of red cell destruction. Folic acid should be used in any disorder featuring a high red cell turnover. Although vitamin E and selenium have antioxidant properties, their use does not decrease the severity of G6PD deficiency.